# Brilliant Earth Group, Inc.: financial statements, quarterly

BRLT · Nasdaq · CIK 1866757 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brlt.md) · [Financials](/companies/brlt/financials.md) · [Filings](/companies/brlt/filings.md) · [Insiders](/companies/brlt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brlt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [114](/filings/0001866757-24-000166.md) | [124 d](/filings/0001866757-25-000038.md) | [97.3](/filings/0001866757-25-000078.md) | [105](/filings/0001866757-25-000116.md) | [99.9](/filings/0001628280-25-049516.md) | [120 d](/filings/0001628280-26-018794.md) | [93.9](/filings/0001628280-26-032129.md) | [109](/filings/0001628280-26-054474.md) | [110](/filings/0001628280-25-049516.md) | [124 d](/filings/0001628280-26-018794.md) | [99.5](/filings/0001628280-26-032129.md) | [115](/filings/0001628280-26-054474.md) |
| Cost of revenue | $m | [47.3](/filings/0001866757-24-000166.md) | [51.3 d](/filings/0001866757-25-000038.md) | [39.0](/filings/0001866757-25-000078.md) | [41.3](/filings/0001866757-25-000116.md) | [39.1](/filings/0001628280-25-049516.md) | [48.3 d](/filings/0001628280-26-018794.md) | [38.8](/filings/0001628280-26-032129.md) | [45.4](/filings/0001628280-26-054474.md) | [46.8](/filings/0001628280-25-049516.md) | [54.9 d](/filings/0001628280-26-018794.md) | [45.4](/filings/0001628280-26-032129.md) | [48.5](/filings/0001628280-26-054474.md) |
| Gross profit | $m | [66.8](/filings/0001866757-24-000166.md) | [73.0 d](/filings/0001866757-25-000038.md) | [58.3](/filings/0001866757-25-000078.md) | [64.1](/filings/0001866757-25-000116.md) | [60.8](/filings/0001628280-25-049516.md) | [71.2 d](/filings/0001628280-26-018794.md) | [55.0](/filings/0001628280-26-032129.md) | [63.5](/filings/0001628280-26-054474.md) | [63.5](/filings/0001628280-25-049516.md) | [69.5 d](/filings/0001628280-26-018794.md) | [54.1](/filings/0001628280-26-032129.md) | [66.6](/filings/0001628280-26-054474.md) |
| Selling, general and administrative | $m | [64.8](/filings/0001866757-24-000166.md) | [71.8 d](/filings/0001866757-24-000040.md) | [57.4](/filings/0001866757-24-000073.md) | [62.9](/filings/0001866757-24-000130.md) | [61.8](/filings/0001866757-24-000166.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [2.0](/filings/0001866757-24-000166.md) | [1.2 d](/filings/0001866757-25-000038.md) | [0.9](/filings/0001866757-25-000078.md) | [1.1](/filings/0001866757-25-000116.md) | [(1.1)](/filings/0001628280-25-049516.md) | [2.4 d](/filings/0001628280-26-018794.md) | [(3.5)](/filings/0001628280-26-032129.md) | [(1.2)](/filings/0001628280-26-054474.md) | [(0.6)](/filings/0001628280-25-049516.md) | [(0.0) d](/filings/0001628280-26-018794.md) | [(8.9)](/filings/0001628280-26-032129.md) | [0.4](/filings/0001628280-26-054474.md) |
| Interest expense | $m | [1.3](/filings/0001866757-23-000195.md) | [1.3 d](/filings/0001866757-24-000040.md) | [1.2](/filings/0001866757-24-000073.md) | [1.3](/filings/0001866757-25-000116.md) | [1.3](/filings/0001628280-25-049516.md) | [1.2 d](/filings/0001628280-26-018794.md) | [1.1](/filings/0001628280-26-032129.md) | [0.9](/filings/0001628280-26-054474.md) | [0.3](/filings/0001628280-25-049516.md) | [0.0 d](/filings/0001628280-26-018794.md) | [0.0](/filings/0001628280-26-032129.md) | [0.0](/filings/0001628280-26-054474.md) |
| Income tax | $m | [0.1](/filings/0001866757-24-000166.md) | [(0.6) d](/filings/0001866757-25-000038.md) | [0.1](/filings/0001866757-25-000078.md) | [(0.1)](/filings/0001866757-25-000116.md) | [0.2](/filings/0001628280-25-049516.md) | [(0.1) d](/filings/0001628280-26-018794.md) | [(0.1)](/filings/0001628280-26-032129.md) | [0.1](/filings/0001628280-26-054474.md) | [0.0](/filings/0001628280-25-049516.md) | [9.6 d](/filings/0001628280-26-018794.md) | [0.0](/filings/0001628280-26-032129.md) | [0.0](/filings/0001628280-26-054474.md) |
| Net income | $m | [0.2](/filings/0001866757-24-000166.md) | [0.2 d](/filings/0001866757-25-000038.md) | [0.1](/filings/0001866757-25-000078.md) | [0.2](/filings/0001866757-25-000116.md) | [(0.1)](/filings/0001628280-25-049516.md) | [0.4 d](/filings/0001628280-26-018794.md) | [(0.5)](/filings/0001628280-26-032129.md) | [(0.2)](/filings/0001628280-26-054474.md) | [(0.1)](/filings/0001628280-25-049516.md) | [(2.9) d](/filings/0001628280-26-018794.md) | [(1.5)](/filings/0001628280-26-032129.md) | [0.0](/filings/0001628280-26-054474.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001866757-24-000166.md) | not reported | [0.01](/filings/0001866757-25-000078.md) | [0.01](/filings/0001866757-25-000116.md) | [(0.01)](/filings/0001628280-25-049516.md) | not reported | [(0.03)](/filings/0001628280-26-032129.md) | [(0.01)](/filings/0001628280-26-054474.md) | [(0.01)](/filings/0001628280-25-049516.md) | not reported | [(0.10)](/filings/0001628280-26-032129.md) | [0.01](/filings/0001628280-26-054474.md) |
| Basic EPS | $ per share | [0.02](/filings/0001866757-24-000166.md) | not reported | [0.01](/filings/0001866757-25-000078.md) | [0.01](/filings/0001866757-25-000116.md) | [(0.01)](/filings/0001628280-25-049516.md) | not reported | [(0.03)](/filings/0001628280-26-032129.md) | [(0.01)](/filings/0001628280-26-054474.md) | [(0.01)](/filings/0001628280-25-049516.md) | not reported | [(0.10)](/filings/0001628280-26-032129.md) | [0.00](/filings/0001628280-26-054474.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [147](/filings/0001866757-24-000166.md) | [156](/filings/0001866757-25-000038.md) | [147](/filings/0001866757-25-000078.md) | [152](/filings/0001866757-25-000116.md) | [153](/filings/0001628280-25-049516.md) | [162](/filings/0001628280-26-018794.md) | [147](/filings/0001628280-26-032129.md) | [134](/filings/0001628280-26-054474.md) | [73.4](/filings/0001628280-25-049516.md) | [79.1](/filings/0001628280-26-054474.md) | [58.6](/filings/0001628280-26-032129.md) | [74.9](/filings/0001628280-26-054474.md) |
| Current assets | $m | [196](/filings/0001866757-23-000195.md) | [205](/filings/0001866757-25-000038.md) | [198](/filings/0001866757-24-000073.md) | [202](/filings/0001866757-24-000130.md) | [203](/filings/0001866757-24-000166.md) | [211](/filings/0001628280-26-018794.md) | [198](/filings/0001866757-25-000078.md) | [191](/filings/0001866757-25-000116.md) | [136](/filings/0001628280-25-049516.md) | [145](/filings/0001628280-26-054474.md) | [127](/filings/0001628280-26-032129.md) | [139](/filings/0001628280-26-054474.md) |
| Total assets | $m | [266](/filings/0001866757-23-000195.md) | [274](/filings/0001866757-25-000038.md) | [268](/filings/0001866757-24-000073.md) | [273](/filings/0001866757-24-000130.md) | [273](/filings/0001866757-24-000166.md) | [281](/filings/0001628280-26-018794.md) | [270](/filings/0001866757-25-000078.md) | [261](/filings/0001866757-25-000116.md) | [203](/filings/0001628280-25-049516.md) | [201](/filings/0001628280-26-054474.md) | [183](/filings/0001628280-26-032129.md) | [197](/filings/0001628280-26-054474.md) |
| Current liabilities | $m | [70.8](/filings/0001866757-23-000195.md) | [76.9](/filings/0001866757-25-000038.md) | [68.7](/filings/0001866757-24-000073.md) | [69.9](/filings/0001866757-24-000130.md) | [72.4](/filings/0001866757-24-000166.md) | [78.2](/filings/0001628280-26-018794.md) | [87.2](/filings/0001866757-25-000078.md) | [115](/filings/0001866757-25-000116.md) | [82.9](/filings/0001628280-25-049516.md) | [90.1](/filings/0001628280-26-054474.md) | [80.5](/filings/0001628280-26-032129.md) | [88.5](/filings/0001628280-26-054474.md) |
| Total liabilities | $m | [172](/filings/0001866757-23-000195.md) | [176](/filings/0001866757-25-000038.md) | [168](/filings/0001866757-24-000073.md) | [170](/filings/0001866757-24-000130.md) | [169](/filings/0001866757-24-000166.md) | [172](/filings/0001628280-26-018794.md) | [167](/filings/0001866757-25-000078.md) | [158](/filings/0001866757-25-000116.md) | [124](/filings/0001628280-25-049516.md) | [121](/filings/0001628280-26-054474.md) | [112](/filings/0001628280-26-032129.md) | [123](/filings/0001628280-26-054474.md) |
| Long-term debt | $m | [56.7](/filings/0001866757-23-000195.md) | [55.6](/filings/0001866757-25-000038.md) | [54.3](/filings/0001866757-24-000073.md) | [53.2](/filings/0001866757-24-000130.md) | [51.6](/filings/0001866757-24-000166.md) | [50.0](/filings/0001628280-26-018794.md) | [34.5](/filings/0001866757-25-000078.md) | [0.0](/filings/0001866757-25-000116.md) | [0.0](/filings/0001628280-25-049516.md) | [0.0](/filings/0001628280-26-018794.md) | not reported | not reported |
| Current portion of debt | $m | [3.7](/filings/0001866757-23-000195.md) | [4.1](/filings/0001866757-25-000038.md) | [4.5](/filings/0001866757-24-000073.md) | [4.9](/filings/0001866757-24-000130.md) | [6.5](/filings/0001866757-24-000166.md) | [5.7](/filings/0001628280-26-018794.md) | [20.0](/filings/0001866757-25-000078.md) | [34.5](/filings/0001866757-25-000116.md) | [0.0](/filings/0001628280-25-049516.md) | [0.0](/filings/0001628280-26-018794.md) | not reported | not reported |
| Shareholders' equity | $m | [11.8](/filings/0001866757-23-000195.md) | [12.5](/filings/0001866757-25-000038.md) | [13.3](/filings/0001866757-24-000073.md) | [14.1](/filings/0001866757-24-000130.md) | [14.5](/filings/0001866757-24-000166.md) | [15.3](/filings/0001628280-26-018794.md) | [14.9](/filings/0001866757-25-000078.md) | [15.3](/filings/0001866757-25-000116.md) | [12.0](/filings/0001628280-25-049516.md) | [12.3](/filings/0001628280-26-054474.md) | [11.4](/filings/0001628280-26-032129.md) | [12.2](/filings/0001628280-26-054474.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.6 d](/filings/0001866757-24-000166.md) | [10.7 d](/filings/0001866757-25-000038.md) | [(5.8)](/filings/0001866757-25-000078.md) | [7.3 d](/filings/0001866757-25-000116.md) | [2.0 d](/filings/0001628280-25-049516.md) | [14.1 d](/filings/0001628280-26-018794.md) | [(7.1)](/filings/0001628280-26-032129.md) | [9.1 d](/filings/0001628280-26-054474.md) | [0.6 d](/filings/0001628280-25-049516.md) | [7.2 d](/filings/0001628280-26-018794.md) | [(18.8)](/filings/0001628280-26-032129.md) | [17.4 d](/filings/0001628280-26-054474.md) |
| Capital expenditure | $m | [1.6 d](/filings/0001866757-24-000166.md) | [1.2 d](/filings/0001866757-25-000038.md) | [0.6](/filings/0001866757-25-000078.md) | [0.9 d](/filings/0001866757-25-000116.md) | [1.3 d](/filings/0001628280-25-049516.md) | [2.2 d](/filings/0001628280-26-018794.md) | [0.7](/filings/0001628280-26-032129.md) | [1.2 d](/filings/0001628280-26-054474.md) | [0.6 d](/filings/0001628280-25-049516.md) | [1.5 d](/filings/0001628280-26-018794.md) | [0.6](/filings/0001628280-26-032129.md) | [0.9 d](/filings/0001628280-26-054474.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-018794.md) | not reported | not reported | [3.8](/filings/0001628280-26-018794.md) | [0.0 d](/filings/0001628280-26-018794.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001866757-24-000166.md) | [0.0 d](/filings/0001866757-25-000038.md) | [0.1](/filings/0001866757-25-000078.md) | [0.2 d](/filings/0001866757-25-000116.md) | [0.2 d](/filings/0001628280-25-049516.md) | [0.2 d](/filings/0001628280-26-018794.md) | [0.2](/filings/0001628280-26-032129.md) | [0.2 d](/filings/0001628280-26-054474.md) | [0.1 d](/filings/0001628280-25-049516.md) | [0.0 d](/filings/0001628280-26-018794.md) | [0.0](/filings/0001628280-26-032129.md) | [0.0 d](/filings/0001628280-26-054474.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [96.6](/filings/0001866757-23-000195.md) | [11.4](/filings/0001866757-24-000073.md) | [96.9](/filings/0001866757-24-000130.md) | [97.2](/filings/0001866757-24-000166.md) | [97.9](/filings/0001866757-25-000078.md) | [98.2](/filings/0001866757-25-000116.md) | [13.5](/filings/0001628280-25-049516.md) | [14.1](/filings/0001628280-26-032129.md) | [14.6](/filings/0001628280-26-054474.md) | [15.0](/filings/0001628280-25-049516.md) | [15.8](/filings/0001628280-26-032129.md) | [102](/filings/0001628280-26-054474.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,583,332 at 2021-11-09, from the cover of the [10-Q filed 2021-11-12](/filings/0001866757-21-000010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.